[What's new in oncodermatology?]

Area of Science:

• Oncodermatology
• Dermatology
• Oncology

Background:

• Skin cancer incidence, including carcinomas and melanoma, continues to rise globally.
• Transplant recipients face significant skin cancer mortality risks.
• Melanoma mortality is increasing despite screening efforts, linked to factors like UV exposure and prior carcinoma diagnoses.

Purpose of the Study:

• To review key developments in the epidemiology and management of skin cancers in 2017.
• To highlight advancements in melanoma and carcinoma treatment, including immunotherapy and targeted therapies.
• To discuss emerging trends like artificial intelligence in skin cancer screening.

Main Methods:

• Literature review of oncodermatology developments in 2017.
• Analysis of epidemiological trends and risk factors for skin cancers.
• Evaluation of new treatment modalities and prognostic indicators.

Main Results:

• Carcinoma rates are increasing, with specific risk factors identified for squamous cell carcinoma, especially in transplant patients.
• Melanoma epidemiology shows rising mortality, occupational UV exposure, and increased risk post-carcinoma.
• Adjuvant immunotherapy and targeted therapy demonstrate significant improvements in melanoma survival without relapse.

Conclusions:

• New classifications like AJCC8 are crucial for melanoma and carcinoma staging.
• Artificial intelligence holds promise for future skin cancer screening.
• Adjuvant immunotherapy and targeted therapies represent a major breakthrough in melanoma management, improving patient outcomes.